Authors: Castera, L Roulot, D Trinchet, JC Beaugrand, M

Citation: L. Castera et al., Hepatitis C virus-related cirrhosis: is antiviral treatment mandatory?, GASTRO CL B, 25(5), 2001, pp. 509-513

Authors: Bissell, DM Roulot, D George, J

Citation: Dm. Bissell et al., Transforming growth factor beta and the liver, HEPATOLOGY, 34(5), 2001, pp. 859-867

Authors: Morice, Y Roulot, D Grando, V Stirnemann, J Gault, E Jeantils, V Bentata, M Jarrousse, B Lortholary, O Pallier, C Deny, P

Citation: Y. Morice et al., Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns, J GEN VIROL, 82, 2001, pp. 1001-1012

Authors: Roulot, D Sevcsik, AM Coste, T Strosberg, AD Marullo, S

Citation: D. Roulot et al., Role of transforming growth factor beta type II receptor in hepatic fibrosis: Studies of human chronic hepatitis C and experimental fibrosis in rats, HEPATOLOGY, 29(6), 1999, pp. 1730-1738

Authors: George, J Roulot, D Koteliansky, VE Bissell, DM

Citation: J. George et al., In vivo inhibition of rat stellate cell activation by soluble transforminggrowth factor beta type II receptor: A potential new therapy for hepatic fibrosis, P NAS US, 96(22), 1999, pp. 12719-12724